These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 3791066
1. Cholinergic receptors in cognitive disorders. Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A. Can J Neurol Sci; 1986 Nov; 13(4 Suppl):521-7. PubMed ID: 3791066 [Abstract] [Full Text] [Related]
4. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. Perry EK, Smith CJ, Court JA, Perry RH. J Neural Transm Park Dis Dement Sect; 1990 Nov; 2(3):149-58. PubMed ID: 2175197 [Abstract] [Full Text] [Related]
6. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Neuroscience; 2000 Nov; 98(1):79-87. PubMed ID: 10858614 [Abstract] [Full Text] [Related]
7. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. Lange KW, Wells FR, Jenner P, Marsden CD. J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140 [Abstract] [Full Text] [Related]
8. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ. J Neural Transm Suppl; 1987 Jan; 24():131-6. PubMed ID: 2824687 [Abstract] [Full Text] [Related]
16. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion. Ruotsalainen S, Miettinen R, MacDonald E, Koivisto E, Sirviö J. Psychopharmacology (Berl); 2000 Feb; 148(2):111-23. PubMed ID: 10663425 [Abstract] [Full Text] [Related]
17. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Trends Pharmacol Sci; 1989 Dec; Suppl():80-4. PubMed ID: 2694529 [Abstract] [Full Text] [Related]
18. Differential regulation of muscarinic and nicotinic receptors by cholinergic stimulation in cultured avian retina cells. Siman RG, Klein WL. Brain Res; 1983 Feb 28; 262(1):99-108. PubMed ID: 6831232 [Abstract] [Full Text] [Related]
19. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Okada H, Ouchi Y, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y. Brain; 2013 Oct 28; 136(Pt 10):3004-17. PubMed ID: 23975517 [Abstract] [Full Text] [Related]
20. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Neuroscience; 1995 Jan 28; 64(2):385-95. PubMed ID: 7700528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]